The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126062811 12606281 1 I 20160726 20160729 20160729 EXP DE-BFARM-16252160 DE-WATSON-2016-16514 WATSON 0.00 N F Y 0.00000 20160729 CN DE DE

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126062811 12606281 1 PS CITALOPRAM CITALOPRAM HYDROBROMIDE 1 Transplacental 20 MG, DAILY N UNCONFIRMED 77034 20 MG UNK QD
126062811 12606281 2 C DIMENHYDRINATE. DIMENHYDRINATE 1 Transplacental 50 MG, QID (DURING 21 - 22 GESTATIONAL WEEK) U 0 50 MG
126062811 12606281 3 C OMEPRAZOLE. OMEPRAZOLE 1 Transplacental 20 MG, PRN (BETWEEN 25 AND 29 GW) U 0 20 MG
126062811 12606281 4 C RENNIE /06879101/ CALCIUM CARBONATEMAGNESIUM CARBONATE 1 Transplacental 6 TIMES A DAY (DURING SECOND TRIMESTER) U 0
126062811 12606281 5 C FOLIO FOLIC ACID 1 Transplacental 0.4 MG, DAILY U 0 .4 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126062811 12606281 1 Depression
126062811 12606281 2 Vomiting in pregnancy
126062811 12606281 3 Dyspepsia
126062811 12606281 4 Dyspepsia
126062811 12606281 5 Prophylaxis of neural tube defect

Outcome of event

Event ID CASEID OUTC COD
126062811 12606281 CA

Reactions reported

Event ID CASEID DRUG REC ACT PT
126062811 12606281 Aortic valve incompetence
126062811 12606281 Dysmorphism
126062811 12606281 Foetal exposure during pregnancy
126062811 12606281 Presbyacusis
126062811 12606281 Ventricular septal defect

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126062811 12606281 5 20141217 20150821 0